Results 61 to 70 of about 14,442 (179)

Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination.

PLoS ONE, 2014
BackgroundThe reported coverage of the measles-rubella (MR) or measles-mumps-rubella (MMR) vaccine is greater than 99.0% in Zhejiang province. However, the incidence of measles, mumps, and rubella remains high.
Zhifang Wang, Rui Yan, Hanqing He, Qian Li, Guohua Chen, Shengxu Yang, Enfu Chen   +6 more
doaj   +1 more source

Immune Dysregulation in Branched Chain Organic Acidemias

Journal of Inherited Metabolic Disease, Volume 49, Issue 4, July 2026.
ABSTRACT Organic acidemias (OAs) are a group of inherited disorders, most commonly caused by defects in mitochondrial enzymes involved in amino acid and fatty acid metabolism. While they characteristically present with metabolic and neurological crises, growing evidence reveals a significant burden of chronic immune dysregulation in some disorders and ...
Abdul L. Shakerdi, Jack Drda, Justin A. Dutta, Jerry Vockley   +3 more
wiley   +1 more source

Anti-rubella, Mumps and Measles IgG Antibodies in Medical Students of Tehran University

Iranian Journal of Allergy, Asthma and Immunology, 2016
Measles, mumps and rubella are viral infectious diseases that may result in serious complications. Since the production of vaccines, the number of cases of these diseases has been dropped.
Maryam Keshavarz, Mohammad Hossein Nicknam, Majid Tebyanian, Mohammad Kazem Shahkarami, Maryam Izad   +4 more
doaj  

An Epidemic of Mumps Reported in a Peripheral Charitable Hospital, Bengaluru, Karnataka [PDF]

Pediatric Infectious Disease
Mumps is a highly contagious, vaccine-preventable disease. It is one of the oldest human illnesses known to humans. Mumps is caused by paramyxovirus, which is a single-stranded ribonucleic acid (RNA) virus. It is a self-limited illness.
Sreepriya Lalitha, Minnie R
doaj   +1 more source

Controversies in Vaccination with Measles, Mumps, Rubella (MMR) Vaccine [PDF]

The Australian Journal of Hospital Pharmacy, 1998
Many people remember the extensive adverse publicity surrounding pertussis vaccine in the 1970s which led to public concern about the safety of vaccines. Subsequently, follow‐up indicated no causal link between pertussis vaccination and brain damage although the risk of recurrent collapse (shock‐like syndrome or so‐called hypotonic‐hyporesponsive ...
openaire   +1 more source

A Case of Genital and Extragenital Warts Unresponsive to Immunotherapy Using Measles, Mumps, Rubella Vaccine. [PDF]

Int Med Case Rep J, 2023
Achdiat PA, Yunitasari, Usman HA, Maharani RH.   +3 more
europepmc   +1 more source

Barriers to measles mumps rubella vaccine acceptance in the three southern border provinces of Thailand. [PDF]

Clin Exp Vaccine Res, 2023
Sirithammaphan U, Chaisang U, Pongrattanamarn K.   +2 more
europepmc   +1 more source

Seroprotection to vaccine‐preventable diseases among workers at a Victorian tertiary hospital

Australian and New Zealand Journal of Public Health, 2016
Objective: To determine seroprotection for the vaccine‐preventable diseases (VPDs) measles, mumps, rubella, varicella and hepatitis B among new employees seen at a Victorian tertiary hospital staff clinic.
Eden C. Andrew, Katherine B. Gibney, Justin Denholm, Karin Leder   +3 more
doaj   +1 more source

Reactogenicity and immunogenicity of a new measles-mumps-rubella vaccine containing RIT 4385 mumps virus strain in healthy Turkish children

The Turkish Journal of Pediatrics, 2000
A total of 44 children aged between 15-18 months were randomly vaccinated either with a new measles-mumps-rubella (MMR) vaccine (Priorix, SmithKline Beecham) or a commercially available MMR vaccine (MMR-II, Merck) to compare the reactogenicity and
G Kanra, M Ceyhan, E Ozmert
doaj  

Completeness of MMR Vaccination and Durability of Vaccine-Induced Antibody Responses in Children with Inflammatory Bowel Disease

Biomedicines
Background: Children with IBD are at increased risk of suboptimal maintenance of vaccine-induced immunity, particularly when the MMR vaccination course is incomplete before diagnosis and initiation of immunosuppressive therapy. We conducted a prospective
Ivan S. Samolygo, Alexey A. Tinkov, Marina A. Manina, Anton S. Antishin, Albina S. Pestova, Ekaterina A. Yablokova, Ekaterina V. Prutskova, Mikhail P. Kostinov, Svetlana I. Erdes   +8 more
doaj   +1 more source